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Abstract 
BACKGROUND: The role of HbA1c level in cognition decline and depression in type 2 diabetic patients is 
reported in some studies.  
AIM: We evaluated the possible significant relationship between HbA1c level and cognition decline and 
depression in type 2 diabetic patients. 
MATERIAL AND METHODS: This descriptive-analytic study was performed on 512 patients with a different 
HbA1c level and ages range. All subjects were administered a structured clinical interview. Cognitive functions 
and depressive disorders were assessed through the Mini-Mental Status Exam (MMSE) and Patient Health 
Questionnaire-9 (PHQ-9) respectively. Chi-square test was used for relationships between variables. 
RESULTS: HbA1c mean in all patients was 7.58%. MMSE score mean in total was 27.28. 83.3% of patients had 
a depressive disorder, and 8.59% of patients had an MMSE score < 24. There was no significant relationship 
between HbA1c level and cognitive problems, but there was a significant relationship between recent memory 
declines with the level of HbA1c (P = 0.03). Also, there was no significant relationship between attention-deficit 
with HbA1c level. 
CONCLUSION: Our finding provides that even though there is no significant difference between HbA1c level and 
cognitive problems and depression, recent memory state in these patients are more affected than the normal 
population and these patients have a worse state of depressive disorders. 
 
 
 
 
 
Introduction 
 
Diabetes mellitus is a chronic long-term 
illness. All types of diabetes are a global public health 
problem, particularly type 2 diabetes [1]. The 
prevalence of diabetes is increasing in many countries 
around the world. By the year 2025, approximately 
380 million people will be diagnosed with type 2 
diabetes [1], [2]. In Iran, in 2011, the prevalence of 
diabetes in the adult population was 11.4% in 2011, 
with a 35% increase compared to the 2005 reports. It 
is estimated that by the year 2030, 9.2 million people 
in Iran will have diabetes [3]. Diabetes mellitus is 
associated with the poor cognitive function of the 
brain. Total grey-matter and hippocampus volume 
affects these associations and reduce it by almost 
50% when adjusted, but there was no correlation for 
white-matter volume [4], [5]. Type 2 diabetes is a 
known risk factor for the development of depression. 
Symptoms and disorders of depression in 
patients with type 2 diabetes are twice as probable as 
the general population [6]. A possible relationship 
between diabetes and cognitive problems has been 
suggested since the discovery of insulin [7]. It’s a 
controversy about how diabetes can affect cognition 
and make cognitive problems in patients. Changes in 
glucose level as hyper or hypoglycemia, an increase 
in insulin level of resistance to it, oxidative stress and 
inflammatory cytokine effects and deposition of beta-
amyloid are possible mechanisms [8]. Recently, 
HbA1c has been used as a diagnostic test for 
diabetes. This is a preferred test for defining glycemic 
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control in people with diabetes. After using HbA1c, as 
a demonstration of the glycemic condition of diabetic 
patients, an inverse correlation has been noted 
between any cognitive measures and depression with 
HbA1c levels, which proposing that inadequate 
glycemic control could be associated with worse 
cognitive function [9], [10].  
The purpose of this study was the use of this 
marker for evaluating glycemic index in diabetic 
patients. We performed this study in type 2 diabetic 
patients referring to the Tehran city (Capital of Iran) 
hospitals. 
 
 
Material and Methods 
 
Study design 
In a retrospective study, the data were from 
632 patients referring to Tehran city hospitals with 
diagnosed Type 2 diabetes mellitus already. 
Diagnosed type 2 diabetes was the only inclusion 
criteria. Patients were recruited between July 2017 to 
March 2018. Five hundred and twelve adults, 219 
males and 293 females with diagnosed type 2 
diabetes by their primary care physicians. Exclusion 
criteria were: dementia, CNS diseases, unstable 
medical diseases, another psychiatric disease 
(including bipolar disorder), dependency on drug or 
alcohol, or history of head trauma. Subjects were not 
admitted if they were taking anti-depressant or 
psychotropic drugs. All diabetic patients were taking 
combinations of insulin and oral hypoglycemic agents 
for blood sugar control. 
 
Data collection tools 
All subjects were administered a structured 
clinical interview. Patient Health Questionnaire-9 
(PHQ-9) which is a 9-question instrument given to 
patients in a primary care setting to screen for the 
presence and severity of depression. Cognitive 
functioning was assessed through the MMSE (Mini-
Mental Status Exam). The MMSE's purpose has been 
not, on its own, to provide a diagnosis for any 
particular neurological entity [8]. It takes 5 to 10 
minutes to administrate the test, and the test 
examines attention, registration (repeating named 
prompts), and calculation, language, recall, ability to 
follow simple commands and orientation [9]. Originally 
it was designed to differentiate organic from functional 
psychiatric patients [10], [11].
 
 
Procedures 
The study was performed following the 
policies of the Human Subject Protection Committees 
and approved by the University Institutional Review 
Board. Written informed consent was obtained from all 
participants after the procedures had been 
successfully explained. All subjects received an in-
person or telephone introductory interview, followed 
by an in-person psychiatric evaluation. This evaluation 
included psychiatric and medical history, health and 
functioning status. All patients were referred to 
laboratories, and after taking a blood sample, HbA1c 
was analysed. This subject was investigated by 
University Ethics group, and the Ethics Code is 
IR.AJAUMS.REC.1396.79. 
 
Statistics 
All data obtained were recorded in tests 
checklists, and the SPSS version 24 (Chicago, Illinois, 
USA) for Windows was used to perform a chi-square 
test for relationships between variables. 
 
 
Results 
 
Of 512 patients with type 2 diabetic disease, 
219 (42.77%) were male, and 293 (57.23%) were 
female. The age range of patients was 33 to 90 years 
old with an average of 61.84. HbA1c mean in all 
patients was 7.58%. The mean of HbA1c in male was 
7.54% and in female was 7.61%. MMSE score mean 
in total was 27.28 of 30 (scores from 14 Min and Max 
to 30). PHQ-9 scores mean in all participants was 
9.58 of 27. The rate of different factors, according to 
gender, is shown in Table 1. 
Table 1: The rate of different factors in 512 patients with 
diabetic disease 
Patients 
Age 
(mean) 
HbA1c 
(%) 
MMSE 
(of 30 scores) 
PHQ-9 
(of 27 score) 
Male 219 (42.77%) 61.93 7.54 27.52 9.14 
Female 293 (57.23%) 61.77 7.61 27.11 9.92 
Total 512 61.84 7.58 27.28 9.58 
MMSE: Mini Mental Status Exam; PHQ-9: Patient Health Questionnaire-9; HbA1c: 
Hemoglobin A1c. 
 
This study showed that the depression rate 
was 83.3% among all patients. It was 84.6% and 
81.7% among female and male respectively. There 
was a significant relationship between age and 
depression (P = 0.022). There was no significant 
statistical association between sex and depression (P 
> 0.05). According to PHQ-9 scores, 184 patients 
have a score between 5-10 which suggesting a mild 
depression. Due to PHQ-9 scores, 160 patients have 
a score between 10-14 which suggesting a moderate 
depressive disorder. Sixty-three patients have a PHQ-
9 score 15-19 reminding of moderately severe 
depression. Twenty patients have a score higher or 
equal to 20 which suggesting a severe depression. 
Other factors related to patients participating in the 
study are presented in Table 2.  
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Table 2: Overview of PHQ-9 test results of 512 patients with 
diabetic disease 
PHQ-9 score range 
(Type of depression) 
Male 
(%) 
Female 
(%) 
Age 
(mean) 
HbA1c 
(%) 
MMSE mean 
(Of 30 scores) 
PHQ-9 mean 
(Of 27 scores) 
≤ 4 (normal) 40 (47.1%) 45 (52.9%) 61.18 7.56 27.74 2.62 
5-10 (mild) 82 (44.6%) 102 (55.4%) 61.13 7.60 27.41 7.06 
10-14 (moderate) 66 (41.3%) 94 (58.7%) 61.94 7.75 27.16 11.8 
15-19 (moderately severe) 22 (34.9%) 41 (65.1%) 63.14 7.60 26.95 16.87 
≥ 20 (severe) 9 (45%) 11 (55%) 66.3 7.52 26.25 21.6 
Total 219 293 61.94 7.57 27.16 11.8 
MMSE: Mini Mental Status Exam; PHQ-9: Patient Health Questionnaire-9; HbA1c: Hemoglobin A1c. 
 
Chi-square test showed no significance 
between HbA1c level and PHQ-9 (P = 0.276). An 
overview of the MMSE test in patients is shown in 
Table 3.  
Table 3: Overview of MMSE test results of 512 patients with 
diabetic disease 
Single cutoff 
method of 
MMSE 
Male Female 
Age 
(mean) 
HbA1c 
(%) 
MMSE mean 
(Of 30 scores) 
PHQ-9 mean 
(Of 27 scores) 
MMSE < 24 14 (31.8%) 30 (68.2%) 69.27 7.74 21.43 10.27 
MMSE: Mini Mental Status Exam; PHQ-9: Patient Health Questionnaire-9; HbA1c: 
Hemoglobin A1c. 
 
In this research, 44 subjects have a score of 
less than 24 on the MMSE test which means a 
possible cognitive problem (Table3). Of this, 14 were 
men (31.8%) and 30 (68.2%) were women. The mean 
of age, HbA1c, MMSE score, PHQ-9 score was 69.27, 
7.74, 21.41 and 10.27 respectively. Statistic test 
showed that there was no significant relationship 
between MMSE score and HbA1c level (P > 0.05). 
Chi-square test showed that there was no significant 
association between sex and age with MMSE score 
less than 24 (P > 0.05) (Table 3). Also, 
there were no significant differences between sex, 
age and MMSE score less than 24 (P > 0.05). Chi-
square test showed that there was no significant 
association between MMSE score and HbA1c level in 
the 33+ (33-49, 50-69, 70-90) age groups (p > 0.05). 
Also, the significant correlation was not observed 
between PHQ-9 score and HbA1c level in all age 
groups (p > 0.05). Also, the mean level of HbA1c is 
higher in clinically depressed patients in contrast with 
not-depressed participants (7.60 and 7.56 
respectively), but there was no significant relationship 
between depression severity and HbA1c level. But 
there was a significant relationship between MMSE 
score and PHQ-9 score with each other in the 
analysis of the entire subjects (P = 0.013).  
In a partial correlation analysis of age groups, 
there was no significant relation between MMSE score 
and PHQ-9 score in the first (33-49) and last (70-90) 
age groups (p > 0.05). But there was a significant 
correlation between those two with 50-69 years old 
group (P < 0.05). After controlling ageing and sex, 
there was no significant relationship between an 
HbA1c level and MMSE score or PHQ-9 score and 
MMSE score and PHQ-9 score in all three age groups 
of male and female except a significant relationship 
between MMSE score and PHQ-9 score in 50-69 
years old group (P < 0.05). We considered Question 4 
(spelling backward) of MMSE for checking attention 
and question 5 (recall 3 words in 5 minutes) for 
checking recent memory. Mean of scores of question 
4 was 4.03 of 5, in male it was 4.35 and there was no 
significant relation with an HbA1c level (P = 0.997), In 
females the score mean was 3.78 but there was no 
significant relationship with an HbA1c level (P = 
0.921) Also there was no significant relation between 
attention deficit and sex (P = 0.130) and age (P = 
0.235). Mean scores of questions 5 were 1.66 0f 3. In 
male score mean was 1.41 and there was a significant 
relation between HbA1c level and recent memory 
impairment (P = 0.03). In females, the mean score 
was 2.10, and there was a significant relationship 
between HbA1c levels and memory impairment (P = 
0.01). Also, there was a significant relation between 
recent memory impairment and sex (P = 0.005). But 
there was no significant relationship between age and 
recent memory impairment (P = 0.231). 
 
 
Discussion 
 
This report aimed to provide the role of HbA1c 
level in cognition decline and depression in type 2 
diabetic patients. The data of 512 patients with Type 2 
diabetes mellitus who referred to Tehran city hospitals 
between July 2017 to March 2018 were collected. 
This study showed that both sexes were susceptible 
to the disease, and most of the patients (83.3%) had a 
depressive disorder in different grades. An 
investigation in Iran reported similar findings. This 
study showed a high level of depression (85.3%) 
among diabetic patients [12]. IN another study, 
researchers reported that depression is more common 
among diabetic patients and 77% of the subjects had 
a severe kind of depressive disorder [13]. The results 
of a study in Iran showed that type 2 diabetic patients 
had a more severe level of depression and depression 
incidence was 72% among them [14]. Our findings 
were consistent with the results of these studies. Our 
study showed that there was a significant difference 
between age and depression, but there was no 
relation between sex and depression. Mahmoudi et al. 
reported a significant relationship between age and 
sex with depression [13]. In some studies, 
researchers in foreign countries reported similar 
results. Ronny et al. showed a 75% rate of depression 
in rural older African Americans, Native Americans, 
and whites’ diabetic patients [15]. This is close to our 
findings. We found a higher prevalence of type 2 
diabetic (84.6%) among female patients. In another 
study, researchers reported a higher prevalence of 
depression among type 2 diabetic patients and they 
also reported that depression has a higher prevalence 
among female patients [16]. Other investigations in 
the Netherlands, US, Bangladesh and Iran continually 
report the raised prevalence of depression in diabetic 
patients, in a range between 5% to 71.8% [17], [18], 
[19], [20], [21]. These studies show a higher level of 
depressive disorders among type 2 diabetic patients, 
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but the prevalence percentage is lower than ours 
because of the lower incidence of depression in those 
countries. Another study in Finland reported no 
significant relationship between cognitive function and 
diabetes. There was no significant difference in 
cognitive scores of the MMSE test; however, the 
female had better performance [22]. The results of this 
study have concordance with our results in Tehran. 
On the other hand, the English physician Thomas 
Willis suggested that in diabetic patients, the mental 
function might not be the same as others. Currently, 
cognition is an important issue in diabetic patient’s 
health, especially for postmenopausal women. 
In a large study, researchers used Telephone 
Interview of Cognitive Status (TICS) and suggested 
an effect of diabetes on cognition state. In this study, 
subjects with diabetes scored lower on mental health 
and energy indices [23]. Also many studies suggest 
positive relationship between diabetes and one or 
more cognitive domains declines, including 
attention/concentration [24], [25], [26], [27], [28], [29] 
which is opposed to our findings. In another study, the 
possible relation between HbA1c level and memory 
decline was evaluated [30]. In this study diabetes was 
related to a 10% faster rate of memory decline and 
higher HbA1c was associated with memory decline. A 
relative biological mechanism that describes the 
association between type 2 diabetes and cognition is 
chronic hyperglycemia as well as hyperinsulinemia 
and deficiency of insulin in the brain. Also, other risk 
factors of memory decline such as severe 
hypoglycemic events and depression are more 
common among type 2 diabetic patients and could 
explain the possible association [30].
 
In this study, there was no significant 
relationship between HbA1c level and cognitive 
disorders and depression, but diabetic patients’ recent 
memory and depression level had been influenced. 
We suggest that these patients go through regular 
memory and depressive state surveys. 
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